|
|
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun
,
Sophie Cereja
,
Sylvie Chevret
,
Emmanuel Raffoux
,
Marie Beaumont
et al.
Journal articles
hal-01237097v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluation of the Impact of the Presence of Neutralizing L-Asparaginase Antibodies on the Efficacy and Safety of Graspa in Phase 3 Randomized Trial Versus Native L-Asparaginase in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)
Yves Bertrand
,
André Baruchel
,
Xavier Thomas
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Blood, 2015, 126 (23), pp.3734
Journal articles
hal-01290438v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Abstract CT113: A phase III, multicenter, randomized study evaluating the efficacy and safety and efficacy of erythrocyte encapsulated l-asparaginase (Ery001) versus native l-asparaginase (L-asp) in combination with COOPRALL regimen in patients with first relapse of acut
Yves Bertrand
,
André Baruchel
,
Xavier Thomas
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Journal articles
hal-01300807v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group
Lionel Adès
,
Xavier Thomas
,
Agnes Cuerci-Bres
,
Raffoux Emmanuel
,
Olivier Spertini
et al.
Blood, 2015, 126 (23), pp.451
Journal articles
hal-01300812v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Raouf Ben Abdelali
,
Vahid Asnafi
,
Thibaut Leguay
,
Nicolas Boissel
,
Agnès Buzyn
et al.
Journal articles
hal-00777203v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
Mathilde Hunault-Berger
,
Thibaut Leguay
,
Xavier Thomas
,
Ollivier Legrand
,
Françoise Huguet
et al.
Journal articles
hal-00821138v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Updated Clinical Activity of Graspa Versus Native l-Asparaginase in Combination with Cooprall Regimen in Phase 3 Randomized Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)
André Baruchel
,
Yves Bertrand
,
Xavier Thomas
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Blood, 2015, 126 (23), pp.3723
Journal articles
hal-01290425v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7)
Xavier Thomas
,
Yves Bertrand
,
André Baruchel
,
Nicolas Blin
,
Emmanuelle Tavernier
et al.
Blood, 2015, 126 (23), pp.2492
Journal articles
hal-01290427v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience
Marie-Anne Couturier
,
Françoise Huguet
,
Patrice Chevallier
,
Felipe Suarez
,
Xavier Thomas
et al.
Journal articles
hal-01231425v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|